ENHO and metabolic disease: Although some previous studies have documented that higher concentrations of BDNF and adropin were related to decreased odds of metabolic disorders through regulating energy hemostasis and its related signaling pathways7–9, there are insufficient data regarding this association and the possible mechanisms.